Cardiovascular and microvascular outcomes of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled cardiovascular outcome trials with trial sequential analysis

Peer Review reports

Original Submission
24 May 2018	Submitted	Original manuscript
17 Jul 2018	Reviewed	Reviewer Report - Hesham Al-Sallami
31 Jul 2018	Reviewed	Reviewer Report - Domenico Capone
18 Aug 2018	Author responded	Author comments - Xiaowen Zhang
Resubmission - Version 2
18 Aug 2018	Submitted	Manuscript version 2
Publishing
28 Aug 2018	Editorially accepted
17 Sep 2018	Article published	10.1186/s40360-018-0246-x

Back to article page